Evidence map›Paper›PMID 15860130›Full record

ArticleAIDS research and therapy2005

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

Karen S Slobod, Chris Coleclough, Scott A Brown, John Stambas, Xiaoyan Zhan, Sherri Surman, Bart G Jones, Amy Zirkel, Pamela J Freiden, Brita Brown and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS research and therapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00051922 (Evaluation of the Safety of a Polyvalent Vaccinia Virus HIV-1 Envelope Recombinant Vaccine), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00051922 phase1completednot on this map

Evaluation of the Safety of a Polyvalent Vaccinia Virus HIV-1 Envelope Recombinant Vaccine (PolyEnv1) in Healthy Adults

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran1997 to 2009Enrolled24ConditionsHIV InfectionsArmsPolyEnv1
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Human immunodeficiency virus vaccine an update.Journal of oral and maxillofacial pathology : JOMFP · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Karen S SlobodDepartment of Infectious Diseases, St Jude Children's Research Hospital, 332 N, Lauderdale, Memphis, TN 38105 USA. julia.hurwitz@stjude.org.
Chris Coleclough
Scott A Brown
John Stambas
Xiaoyan Zhan
Sherri Surman
Bart G Jones
Amy Zirkel
Pamela J Freiden
Brita Brown
Robert Sealy
Mattia Bonsignori
Julia L Hurwitz

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
SINGLE CELL ANALYSIS OF A MULTI-TIER AIDS VACCINEP01AI045142 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HURWITZ, JULIA L · 1999 to 2004
$7.0M
NCI NIH HHS P30 CA021765NIAID NIH HHS P01 AI045142
6 · The paper itself

Abstract

Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a unique vaccine for every world region or virus subtype may not be necessary.

Identifiers

PMID15860130
PMCPMC1112584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.